Contemporary model for cardiovascular risk prediction in people with type 2 diabetes

Andre Pascal Kengne, Anushka Patel, Michel Marre, Florence Travert, Michel Lievre, Sophia Zoungas, John Chalmers, Stephen Colagiuri, Diederick E. Grobbee, Pavel Hamet, Simon Heller, Bruce Neal, Mark Woodward

Research output: Contribution to journalArticle

Abstract

Background: Existing cardiovascular risk prediction equations perform non-optimally in different populations with diabetes. Thus, there is a continuing need to develop new equations that will reliably estimate cardiovascular disease (CVD) risk and offer flexibility for adaptation in various settings. This report presents a contemporary model for predicting cardiovascular risk in people with type 2 diabetes mellitus. Design and methods: A 4.5-year follow-up of the Action in Diabetes and Vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) cohort was used to estimate coefficients for significant predictors of CVD using Cox models. Similar Cox models were used to fit the 4-year risk of CVD in 7168 participants without previous CVD. The model's applicability was tested on the same sample and another dataset. Results: A total of 473 major cardiovascular events were recorded during follow-up. Age at diagnosis, known duration of diabetes, sex, pulse pressure, treated hypertension, atrial fibrillation, retinopathy, HbA1c, urinary albumin/creatinine ratio and non-HDL cholesterol at baseline were significant predictors of cardiovascular events. The model developed using these predictors displayed an acceptable discrimination (c-statistic: 0.70) and good calibration during internal validation. The external applicability of the model was tested on an independent cohort of individuals with type 2 diabetes, where similar discrimination was demonstrated (c-statistic: 0.69). Conclusions: Major cardiovascular events in contemporary populations with type 2 diabetes can be predicted on the basis of routinely measured clinical and biological variables. The model presented here can be used to quantify risk and guide the intensity of treatment in people with diabetes.

Original languageEnglish (US)
Pages (from-to)393-398
Number of pages6
JournalEuropean Journal of Cardiovascular Prevention and Rehabilitation
Volume18
Issue number3
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Cardiovascular Models
Type 2 Diabetes Mellitus
Cardiovascular Diseases
perindopril drug combination indapamide
Proportional Hazards Models
Gliclazide
Vascular Diseases
Atrial Fibrillation
Calibration
Population
Albumins
Creatinine
Cholesterol
Blood Pressure
Hypertension

Keywords

  • Cardiovascular diseases
  • Diabetes mellitus
  • Prevention
  • Prognosis
  • Risk score

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Epidemiology

Cite this

Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. / Kengne, Andre Pascal; Patel, Anushka; Marre, Michel; Travert, Florence; Lievre, Michel; Zoungas, Sophia; Chalmers, John; Colagiuri, Stephen; Grobbee, Diederick E.; Hamet, Pavel; Heller, Simon; Neal, Bruce; Woodward, Mark.

In: European Journal of Cardiovascular Prevention and Rehabilitation, Vol. 18, No. 3, 06.2011, p. 393-398.

Research output: Contribution to journalArticle

Kengne, AP, Patel, A, Marre, M, Travert, F, Lievre, M, Zoungas, S, Chalmers, J, Colagiuri, S, Grobbee, DE, Hamet, P, Heller, S, Neal, B & Woodward, M 2011, 'Contemporary model for cardiovascular risk prediction in people with type 2 diabetes', European Journal of Cardiovascular Prevention and Rehabilitation, vol. 18, no. 3, pp. 393-398. https://doi.org/10.1177/1741826710394270
Kengne, Andre Pascal ; Patel, Anushka ; Marre, Michel ; Travert, Florence ; Lievre, Michel ; Zoungas, Sophia ; Chalmers, John ; Colagiuri, Stephen ; Grobbee, Diederick E. ; Hamet, Pavel ; Heller, Simon ; Neal, Bruce ; Woodward, Mark. / Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. In: European Journal of Cardiovascular Prevention and Rehabilitation. 2011 ; Vol. 18, No. 3. pp. 393-398.
@article{2a61d5535bf941fbb1dadbc8f3e45b70,
title = "Contemporary model for cardiovascular risk prediction in people with type 2 diabetes",
abstract = "Background: Existing cardiovascular risk prediction equations perform non-optimally in different populations with diabetes. Thus, there is a continuing need to develop new equations that will reliably estimate cardiovascular disease (CVD) risk and offer flexibility for adaptation in various settings. This report presents a contemporary model for predicting cardiovascular risk in people with type 2 diabetes mellitus. Design and methods: A 4.5-year follow-up of the Action in Diabetes and Vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) cohort was used to estimate coefficients for significant predictors of CVD using Cox models. Similar Cox models were used to fit the 4-year risk of CVD in 7168 participants without previous CVD. The model's applicability was tested on the same sample and another dataset. Results: A total of 473 major cardiovascular events were recorded during follow-up. Age at diagnosis, known duration of diabetes, sex, pulse pressure, treated hypertension, atrial fibrillation, retinopathy, HbA1c, urinary albumin/creatinine ratio and non-HDL cholesterol at baseline were significant predictors of cardiovascular events. The model developed using these predictors displayed an acceptable discrimination (c-statistic: 0.70) and good calibration during internal validation. The external applicability of the model was tested on an independent cohort of individuals with type 2 diabetes, where similar discrimination was demonstrated (c-statistic: 0.69). Conclusions: Major cardiovascular events in contemporary populations with type 2 diabetes can be predicted on the basis of routinely measured clinical and biological variables. The model presented here can be used to quantify risk and guide the intensity of treatment in people with diabetes.",
keywords = "Cardiovascular diseases, Diabetes mellitus, Prevention, Prognosis, Risk score",
author = "Kengne, {Andre Pascal} and Anushka Patel and Michel Marre and Florence Travert and Michel Lievre and Sophia Zoungas and John Chalmers and Stephen Colagiuri and Grobbee, {Diederick E.} and Pavel Hamet and Simon Heller and Bruce Neal and Mark Woodward",
year = "2011",
month = "6",
doi = "10.1177/1741826710394270",
language = "English (US)",
volume = "18",
pages = "393--398",
journal = "European Journal of Preventive Cardiology",
issn = "2047-4873",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Contemporary model for cardiovascular risk prediction in people with type 2 diabetes

AU - Kengne, Andre Pascal

AU - Patel, Anushka

AU - Marre, Michel

AU - Travert, Florence

AU - Lievre, Michel

AU - Zoungas, Sophia

AU - Chalmers, John

AU - Colagiuri, Stephen

AU - Grobbee, Diederick E.

AU - Hamet, Pavel

AU - Heller, Simon

AU - Neal, Bruce

AU - Woodward, Mark

PY - 2011/6

Y1 - 2011/6

N2 - Background: Existing cardiovascular risk prediction equations perform non-optimally in different populations with diabetes. Thus, there is a continuing need to develop new equations that will reliably estimate cardiovascular disease (CVD) risk and offer flexibility for adaptation in various settings. This report presents a contemporary model for predicting cardiovascular risk in people with type 2 diabetes mellitus. Design and methods: A 4.5-year follow-up of the Action in Diabetes and Vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) cohort was used to estimate coefficients for significant predictors of CVD using Cox models. Similar Cox models were used to fit the 4-year risk of CVD in 7168 participants without previous CVD. The model's applicability was tested on the same sample and another dataset. Results: A total of 473 major cardiovascular events were recorded during follow-up. Age at diagnosis, known duration of diabetes, sex, pulse pressure, treated hypertension, atrial fibrillation, retinopathy, HbA1c, urinary albumin/creatinine ratio and non-HDL cholesterol at baseline were significant predictors of cardiovascular events. The model developed using these predictors displayed an acceptable discrimination (c-statistic: 0.70) and good calibration during internal validation. The external applicability of the model was tested on an independent cohort of individuals with type 2 diabetes, where similar discrimination was demonstrated (c-statistic: 0.69). Conclusions: Major cardiovascular events in contemporary populations with type 2 diabetes can be predicted on the basis of routinely measured clinical and biological variables. The model presented here can be used to quantify risk and guide the intensity of treatment in people with diabetes.

AB - Background: Existing cardiovascular risk prediction equations perform non-optimally in different populations with diabetes. Thus, there is a continuing need to develop new equations that will reliably estimate cardiovascular disease (CVD) risk and offer flexibility for adaptation in various settings. This report presents a contemporary model for predicting cardiovascular risk in people with type 2 diabetes mellitus. Design and methods: A 4.5-year follow-up of the Action in Diabetes and Vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) cohort was used to estimate coefficients for significant predictors of CVD using Cox models. Similar Cox models were used to fit the 4-year risk of CVD in 7168 participants without previous CVD. The model's applicability was tested on the same sample and another dataset. Results: A total of 473 major cardiovascular events were recorded during follow-up. Age at diagnosis, known duration of diabetes, sex, pulse pressure, treated hypertension, atrial fibrillation, retinopathy, HbA1c, urinary albumin/creatinine ratio and non-HDL cholesterol at baseline were significant predictors of cardiovascular events. The model developed using these predictors displayed an acceptable discrimination (c-statistic: 0.70) and good calibration during internal validation. The external applicability of the model was tested on an independent cohort of individuals with type 2 diabetes, where similar discrimination was demonstrated (c-statistic: 0.69). Conclusions: Major cardiovascular events in contemporary populations with type 2 diabetes can be predicted on the basis of routinely measured clinical and biological variables. The model presented here can be used to quantify risk and guide the intensity of treatment in people with diabetes.

KW - Cardiovascular diseases

KW - Diabetes mellitus

KW - Prevention

KW - Prognosis

KW - Risk score

UR - http://www.scopus.com/inward/record.url?scp=79959270065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959270065&partnerID=8YFLogxK

U2 - 10.1177/1741826710394270

DO - 10.1177/1741826710394270

M3 - Article

C2 - 21450612

AN - SCOPUS:79959270065

VL - 18

SP - 393

EP - 398

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

SN - 2047-4873

IS - 3

ER -